Breast cancer is a heterogeneous disease in which treatment is complicated by varying degrees of steroid hormone/HER2 sensitivity and the development of resistance to therapies targeting the actions of these hormones and growth factors. The gene discussed is ERBB2; the disease is breast carcinoma.